Form 4: Sera Prognostics Chief Scientific Officer Boniface Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


John J. Boniface, Chief Scientific Officer of Sera Prognostics, sold 5,022 shares of Class A Common Stock on August 7, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

  • On August 7, 2024, John J. Boniface, the Chief Scientific Officer of Sera Prognostics, sold 5,022 shares of Class A Common Stock.
  • The shares were sold at a weighted average price of $7.42.
  • The sale was mandated by the issuer to cover tax withholding obligations related to the vesting of restricted stock units.
  • Following the transaction, Boniface directly owns 129,847 shares of Sera Prognostics.
  • The shares were sold as part of a block trade with prices ranging from $6.94 to $7.58.

Sentiment

Score: 5

Explanation: Neutral sentiment as the transaction is a routine sale of shares to cover tax obligations and doesn't necessarily reflect a positive or negative outlook on the company.

Industry Context

This is a routine Form 4 filing, indicating a sale of shares by a company insider. Such filings are common and provide transparency into the transactions of company executives and directors. The sale was to cover tax obligations, which is a typical reason for insider sales.

Stakeholder Impact

  • The sale of shares by an insider could have a minor impact on shareholder sentiment, but is unlikely to have a significant effect given the reason for the sale.

Key Dates

DateDescription
08/07/2024Date of transaction: John J. Boniface sold 5,022 shares of SERA.
08/08/2024Date of report filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.